
| Serial Number | 99319270 |
| Word Mark | LEERINK PARTNERS UK |
| Filing Date | Monday, August 4, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, April 1, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| NOT AVAILABLE | PARTNERS |
| Goods and Services | Business consulting; acquisition and merger consultation; providing trade information; compiling financial, securities, stock exchange, trade and quote, index value and other financial market information for business purposes; business intermediary services relating to the matching of potential investors with corporations and entrepreneurs needing funding; business consultation services, namely, business evaluation regarding firms in the biotechnology and health fields for the assessment of the non-financial business value of medical technology |
| Goods and Services | Providing online non-downloadable content, namely, reports and articles in the fields of financial matters and business consulting; Providing non-downloadable instructional videos and podcasts in the field of finance via a website; Providing online non-downloadable content, namely, reports and articles in the fields of financial matters, financial trading, investments, raising capital and capital structure, mergers and acquisitions, debt, and private and public equity; Arranging and conducting conferences and events for educational purposes in the field of finance |
| Section 2(f) Limitation Statement | LEERINK has become distinctive of the goods/services as evidenced by the ownership on the Principal Register for the same mark for sufficiently similar goods/services of active U.S. Registration No(s). 8074042 |
| Goods and Services | Financial consulting; Investment banking services; Financial consulting and advising in the field of mergers and acquisitions; Financial consulting and advising in the field of private and public equity; Financial asset management; Investment advisory and fund management services, and investment consultation; Financial services, namely, operation, administration, and management of private equity funds, venture capital funds, hedge funds, capital investment funds and collective investment vehicles, and raising equity capital for others; Business brokerage services and related consulting pertaining to business sales, mergers, acquisitions and business valuations; Financial services, namely, investment advice, investment management, investment consultation, and investment of funds for others, including private and public equity and debt investment services; Financial services, namely consulting and advising in the field of raising capital and capital structure; Financial services, namely consulting and advising in the field of debt and equity placement transactions; Financial research and equity research brokerage services; Information, advisory, consultancy and financial research services relating to finance and investments; Trading of stocks, equity, securities, and securities index futures; Trade underwriting, structuring, and restructuring, namely, financial services in the nature of securities underwriting and financial consultation in the field of capital structure and restructuring; Financial services, namely, the trading of financial instruments, securities, shares, options and other derivative products; Providing financial services with respect to securities and other financial instruments and products, namely, trading of and investments in securities and financial instruments and products for others; Providing an internet website portal featuring information in the field of finance and in the finance fields of financial, banking, and investment transactions, and payment processing services; Providing information in the field of finance and in the finance fields of financial stock and equity markets, mergers and acquisitions, debt, private and public equity, and capital structure and investments; financial evaluation regarding firms in the biotechnology and health fields for the assessment of the financial value of medical technology |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 4, 2025 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 4, 2025 |
| Primary Code | 036 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 4, 2025 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Leerink Intermediate Holdings LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Boston, MA 02109 US |
| Event Date | Event Description |
| Monday, August 4, 2025 | NEW APPLICATION ENTERED |
| Monday, August 4, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, December 12, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, December 18, 2025 | ASSIGNED TO EXAMINER |
| Monday, December 29, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, December 29, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, December 29, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 30, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 30, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 1, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |